Management Strategies of Recent Viral Disease Outbreaks: Progress and Challenges

Dear Colleagues,

Since the beginning of the pandemic, new “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” variants have emerged that have the ability to influence the airborne transmission, virulence, and immune evasion of affected individuals. Many other viral outbreaks have also been observed recently, such as HFMD, Hongkong fever, H3N2, Langya virus, monkeypox, etc. Many outbreaks of diseases, particularly those caused by viral pathogens, pose a grave risk to public health in the present day. Many illnesses have the potential to become pandemics with devastating global repercussions. We must prepare for future viral outbreaks by developing efficient and effective techniques to contain the infection and prevent the development of a COVID-19-like pandemic, which had severe effects on the health, social, economic, and professional aspects of people worldwide, with the impact being more pronounced in low-income countries and poor segments of the population. Hence, to preserve normality, it is essential to establish mitigation techniques and show preparation in advance.

We welcome contributions to this Special Issue on “Management Strategies of Recent Viral Disease Outbreaks: Progress and Challenges". The goal is to provide comprehensive information on all aspects of research related to recent viral outbreaks, molecular mechanisms, epidemiology, and therapeutic management, with a special emphasis on vaccine development.

This Special Issue seeks all types of manuscripts (e.g., reviews, research articles, and short communications). We cordially invite you to contribute to this Special Issue to advance our knowledge of recent viral outbreaks and to discover the means to overcome them.

Dr. Vivek P. Chavda
Dr. Solomon O. Odemuyiwa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• SARS-CoV-2
• Langya virus
• Monkeypox
• H3N2
• Hongkong fever
• respiratory syncytial virus
• Marburg virus
• Rift Valley fever virus
• acute hepatitis in children
• Sudan Ebola virus
• West Nile virus
• immunological studies
• tracking the viral antigenic shift associated with different viral variants
• viral antigen exploration
• viral proteome vaccine platform and vaccinations
• whole-virus vaccine proteome change analysis during Vero culturing and propagation
• adaptive immunity post-infection and/or vaccination
• T- and B-cell immune response induction and durability